score, we remand that counterclaim for further proceedings. I. In 1983, the United States sued Dr. Stan- islaw R. Burzynski and the Burzynski Can- cer Research Institute (together referred to as Dr. Burzynski) in this civil action seek- ing to enjoin them from violating the Fed- eral Food, Drug, and Cosmetic Act' by